Dulabh Monga
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Pittsburgh, PA 15212Call today!
Primary Specialty
Oncologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Female
Education
Dayanand Medical College
Training
Allegheny General Hospital, University Health Center of Pittsburgh
Certification
American Board of Internal Medicine-Medical Oncology
About
Dr. Monga is closely involved with the Cancer Bridges Support Group Program. She has done extensive clinical research and published original research, review articles and abstracts and mentored residents and fellows with their scholarly projects. She has served as the Principal Investigator for numerous clinical trials. She served as the Program Director of the Hematology Oncology Fellowship Program for 11 years.
Dr. Monga has a passion for teaching medical students, residents and fellows and has been recognized for her dedication, mentorship, and excellence in teaching multiple times. Her passion is providing high quality multidisciplinary care that brings not only the best outcomes but maintains the quality of life of patients with pancreas cancer and other GI malignancies. She was awarded the Clinical Excellence Award from the National Pancreas Foundation in 2025. Dr. Monga has been named “Top Doctor” as chosen by her peers and featured in Pittsburgh Magazine for 2024 and 2025.
Dulabh Monga
Dr. Dulabh K. Monga is an Associate Professor of Medicine at Drexel University School of Medicine. She has been a GI Medical Oncologist practicing for the past 20 years. She is the lead for the Pancreas Cancer Disease Site Leadership Program at Allegheny Health Network and the Director of the Annual Pancreas Symposium.Dr. Monga is closely involved with the Cancer Bridges Support Group Program. She has done extensive clinical research and published original research, review articles and abstracts and mentored residents and fellows with their scholarly projects. She has served as the Principal Investigator for numerous clinical trials. She served as the Program Director of the Hematology Oncology Fellowship Program for 11 years.
Dr. Monga has a passion for teaching medical students, residents and fellows and has been recognized for her dedication, mentorship, and excellence in teaching multiple times. Her passion is providing high quality multidisciplinary care that brings not only the best outcomes but maintains the quality of life of patients with pancreas cancer and other GI malignancies. She was awarded the Clinical Excellence Award from the National Pancreas Foundation in 2025. Dr. Monga has been named “Top Doctor” as chosen by her peers and featured in Pittsburgh Magazine for 2024 and 2025.
Services
hilar cholangiocarcinoma, neuroendocrine tumors, gastrointestinal (gi) stromal tumors, colorectal metastases, intestinal cancer, liver metastases, appendiceal cancer chemotherapy, appendiceal cancer, small intestine cancer chemotherapy, small bowel cancer, cholangiocarcinoma, neuroendocrine tumor of the appendix, neuroendocrine tumor of the bowel, neuroendocrine tumor of duodenum, neuroendocrine carcinoma, metastatic gastric cancer, familial intestinal gastric cancer, stomach cancer chemotherapy, esophageal cancer, anal carcinoma in situ, anal cancer chemotherapy, anal cancer, abdominal cancer, gallbladder cancer, gastrointestinal (gi) cancer, colorectal malignancy, adjuvant chemotherapy, cancer chemotherapy, multi-cancer early detection blood test, solid tumors, advanced malignancies, systemic therapy, intravesical chemotherapy, personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), blood transfusion therapy, metastatic rib cancer, intravesical therapy, carcinoma of unknown primary, targeted molecular therapy, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, clinical trials, intraarterial chemotherapy of tumors, malignant carcinoid tumor of colon, cancer immunotherapy, abdominal chemotherapy, reduced intensity conditioning regimens, stomach cancer, side effects of cancer treatment, pancreas cancer, metastatic colon cancer, liver cancer, intraperitoneal hyperthermic chemoperfusion, colon cancer chemotherapy, cancer pain, cancer genomics, cancer during pregnancy, biological targeted therapy, cancer
Business Hours
Monday:10:00 AM - 4:00 PM
Tuesday:10:00 AM - 4:00 PM
Wednesday:10:00 AM - 4:00 PM
Thursday:10:00 AM - 4:00 PM
Friday:10:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed